2013~2019年我院药品不良反应报告分析  

Analysis of adverse drug reaction reports in our hospital in 2013~2019

作　　者：张月琴[1] 关颖卓[1] 赵秋红[2] 宋玉暄 Zhang Yueqin;Guan Yingzhuo;Zhao Qiuhong(Beijing Aerospace General Hospital,Beijing 100076)

机构地区：[1]北京航天总医院药剂科,100076 [2]北京航天总医院呼吸内科,100076 [3]北京航天总医院妇产科,100076

出　　处：《中国现代医药杂志》2020年第4期29-32,共4页Modern Medicine Journal of China

摘　　要：目的分析我院药品不良反应发生的特点及规律。方法回顾性分析我院2013~2019年上报国家ADR监测系统的药品不良反应报告,对相关因素进行统计与分析。结果 80份ADR报告中,男37例(46.25%),女43例(53.75%);>60岁患者最多,共45例(56.25%);严重的ADR 8例(10.00%),其中1例死亡;新的ADR 4例(5.00%);静脉滴注给药引起的ADR最多,共51例(63.75%);ADR因果关系评价为"可能"的最多,共52例(65.00%)。结论临床应加强并重视ADR的监测与报告工作,合理选择药物以保障患者用药安全。Objective To analyze the characteristics and regularity of adverse drug reaction in our hospital. Methods Retrospectively analyzed adverse drug reaction reports to the national ADR monitoring system in 2013~2019, and made some statistics and analysis of relevant factors. Results There were 37 male patients (46.25%) and 43 female patients (53.75%) in 80 ADR reports. There were 45 cases (56.25%) whose age was over 60 years old. 8 cases (10.00%) were serious ADR, 1 case died. 4 cases were new ADR (5.00%). Most ADRs were caused by intravenous drip (51 cases, 63.75%). ADR causality was most likely to be evaluated as "possible", there were 52 cases (65.00%). Conclusion It suggested that we should enhance and pay attention to ADR monitoring and reporting, in order to protect medication safety of patients by selecting drugs reasonably.

关 键 词：药品不良反应 评价 分析 

分 类 号：R95[医药卫生—药学]